Mount Sinai has developed a machine learning model forecasting the cardiovascular risk impact of CPAP in obstructive sleep apnea patients.
Key Details
- 1Mount Sinai team used machine learning to analyze data from over 2,600 patients in the SAVE trial.
- 2The model estimates whether CPAP usage will benefit or harm individual cardiovascular risk profiles.
- 3Substantial differences in treatment response were discovered across patient subgroups, with up to 100-fold differences in outcomes.
- 4Model is based on 23 selected baseline predictors from over 100 sleep and health variables.
- 5Findings highlight potential for precision medicine in treating sleep apnea and associated cardiovascular risks.
Why It Matters
This study marks a step towards personalized medicine using AI, supporting tailored treatment plans in sleep medicine and cardiovascular disease. The approach underscores the value of advanced analytics in stratifying risk and improving patient outcomes, reflecting broader trends toward individualized AI-powered decision support in clinical settings.
Source
EurekAlert
Related News
•EurekAlert
AI and Deep Learning Reveal Menopause's Asynchronous Impact on Female Organs
An AI-powered atlas maps how menopause uniquely affects aging in individual female reproductive organs using tissue imaging and gene expression data.
•EurekAlert
AI State-Space Model Enhances Hyperspectral Image Resolution
Researchers introduce PLGMamba, an innovative AI model improving hyperspectral image super-resolution by leveraging local-global spectral feature modeling.
•EurekAlert
AI Model Detects Ultra-Early Pancreatic Cancer on CT Beyond Human Capability
Researchers validate the REDMOD AI framework, which detects early, otherwise invisible, tissue changes of pancreatic cancer on CT scans before clinical diagnosis.